Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver, Cancer Of, Non-Resectable”

632 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 632 results

Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Not applicableLooking for participantsNCT02864485
What this trial is testing

Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
University Health Network, Toronto 20
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Testing effectiveness (Phase 2)Ended earlyNCT00787787
What this trial is testing

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Washington 41
Testing effectiveness (Phase 2)Study completedNCT01639352
What this trial is testing

Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Lynn Feun 20
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Early research (Phase 1)Study completedNCT00001576
What this trial is testing

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Who this might be right for
Colorectal NeoplasmLiver NeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Large-scale testing (Phase 3)Ended earlyNCT02200042
What this trial is testing

Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer

Who this might be right for
Stage III Intrahepatic CholangiocarcinomaStage IVA Intrahepatic Cholangiocarcinoma
NRG Oncology 1
Testing effectiveness (Phase 2)Study completedNCT00052364
What this trial is testing

Oxaliplatin in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Looking for participantsNCT04522544
What this trial is testing

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectableHCC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 55
Not applicableLooking for participantsNCT06746194
What this trial is testing

The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ruijin Hospital 40
Early research (Phase 1)Temporarily pausedNCT06217094
What this trial is testing

Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Who this might be right for
Hepatocellular Carcinoma
University of Florida 18
Not applicableEnded earlyNCT01817205
What this trial is testing

Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314372
What this trial is testing

FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC)Liver Cancer Adult
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 86
Not applicableStudy completedNCT04576572
What this trial is testing

Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerAdvanced Adult Hepatocellular Carcinoma+3 more
Inonu University 424
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Testing effectiveness (Phase 2)Study completedNCT00049322
What this trial is testing

Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center 30
Not applicableNot Yet RecruitingNCT05660213
What this trial is testing

Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

Who this might be right for
Unresectable Hepatocellular Carcinoma
Fudan University 750
Post-approval studies (Phase 4)Study completedNCT01332669
What this trial is testing

Drug-eluting Bead in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 200
Load More Results